AcrIIA7劫持了tracrRNA以阻止CRISPR-Cas系统的使用
So Yeon Lee1,2, Hyun Ho Park3,4
1College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea.
Nature communications
|March 15, 2026
概括
一种新型的抗CRISPR蛋白,AcrIIA7,通过与tracrRNA结合来抑制CRISPR-Cas9,从而阻止了必需的核核蛋白复合体的形成. 这一发现揭示了一种新的RNA向机制,用于阻止CRISPR免疫力.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 生物化学 生化学
背景情况:
- 克里斯普尔-Cas9系统是一种强大的基因编辑工具,依赖于核糖核蛋白 (RNP) 复合体.
- 反CRISPR蛋白 (Acrs) 是已知的CRISPR-Cas系统的抑制剂,但它们的机制尚未完全理解.
- 此前,AcrIIA7对Cas9的抑制机制尚不清楚.
研究的目的:
- 阐明抗CRISPR蛋白AcrIIA7对抗CRISPR-Cas9系统的抑制机制.
- 确定AcrIIA7与Cas9组件相互作用的结构基础.
- 为了确定用于CRISPR-Cas系统抑制的新策略.
主要方法:
- 进行X射线晶体学以确定AcrIIA7.7.的结构.
- 生物化学试验分析了AcrIIA7,Cas9,crRNA和tracrRNA之间的相互作用.
- 结构分析以了解结合界面和抑制机制.
主要成果:
- 确定了AcrIIA7的结构,揭示了其独特的抑制机制.
- AcrIIA7 特别与转激活的CRISPRRNA (tracrRNA) 结合.
- 这种结合阻止了tracrRNA与CRISPR衍生的RNA (crRNA) 的结合,抑制了活性Cas9 RNP复合物的形成.
结论:
- AcrIIA7采用了一种新的"tracrRNA劫持"机制来抑制CRISPR-Cas9.
- 这项研究提供了对tracrRNA向的抗CRISPR活性的第一个结构性见解.
- RNA-RNA相互作用接口被确定为调节CRISPR-Cas免疫力的关键目标.
相关概念视频
CRISPR
58.7K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.7K
CRISPR
18.8K
18.8K
The Antiviral System of Bacteria and Archaea: CRISPR
899
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
899
CRISPR and crRNAs
19.5K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
19.5K
CRISPR/Cas9 Genome Editing
2.4K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.4K
RNA Interference
28.4K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.4K


